Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters

For anti-aging and skin rejuvenation, inject 1-2mg subcutaneously 3-5 times weekly for 8-12 weeks minimum
Early research suggested that the tripeptide bonds of standard generic glutathione were rapidly degraded by peptidases and stomach acids in the gastrointestinal tract, leading to poor systemic bioavailability
Studies have demonstrated that GHK-Cu can enhance cognitive performance and provide neuroprotection
2010;32(9):11257 Patel V, Fisher M, Voelker M, et al
It's important to note that individual reactions can vary, and what's rare for most might be more common for some